Rheumnow Podcast

Dr. Philip Mease, a renowned rheumatologist, presents compelling findings on the long-term safety of Bimekizumab for treating axial spondyloarthritis and psoriatic arthritis. Meanwhile, Dr. Eric Dein dives into the nuanced world of rheumatoid arthritis, discussing the critical distinctions between low disease activity and clinical remission. They also explore the implications of statin use alongside JAK inhibitors, shedding light on how these factors affect treatment strategies. Tune in for insights that could reshape RA management!

Delve into the complexities of assessing axial spondyloarthritis with updated measurement techniques. Discover new strategies for managing difficult cases and the surprising prevalence of Diffuse Idiopathic Skeletal Hyperostosis. Explore the exciting yet controversial role of generative AI in rheumatology and its impact on racial disparities in health outcomes. Learn about innovative precision immunotherapy approaches targeting specific T-cell receptors in ankylosing spondylitis. Lastly, uncover the latest steroid-sparing strategies for treating Giant Cell Arteritis and Polymyalgia Rheumatica.

Dr. Andrea Fava, a researcher specializing in autoimmune diseases, discusses groundbreaking research on fibroblasts and their role in conditions like lupus. She introduces an innovative urinary biomarker that could revolutionize lupus nephritis diagnosis. The podcast also highlights legislative efforts for better healthcare access and underscores the importance of monitoring cardiovascular health in autoimmune patients. Additionally, discussions touch on gender differences in disease management, advocating for tailored approaches to improve patient outcomes.

Rinaldi Day, a clinical fellow from London, and Eric Dian, a rheumatologist from Summit, New Jersey, dive into the cutting-edge insights from the ACR Annual Meeting. They discuss a pivotal study linking steroid use to cardiovascular events in rheumatoid arthritis and share findings on optimizing treatment for giant cell arteritis. The conversation touches on racial biases in lung function calculations and the disparities in medication outcomes for connective tissue diseases, highlighting the urgent need for improved management strategies and monitoring.

Joining the discussion are Peter Nash, an expert on JAK inhibitors, Mrinalini Dey, a rheumatologist focusing on methotrexate side effects, and Chris Wincup, who dives into neuropsychiatric lupus. They reveal fascinating insights into JAK inhibitors, their safety, and the importance of vaccinations. Dey shifts perspectives on methotrexate side effects, while she and Wincup emphasize recognizing neuropsychiatric symptoms in lupus, advocating for improved communication and awareness in patient care.

Discover the long-term benefits of bimekizumab for psoriatic arthritis, showcasing improved patient quality of life. Unpack the revolutionary CAR-T therapy's potential for lupus treatment, along with personal patient insights. Dive into gender differences impacting treatment responses in ankylosing spondylitis and the metabolic factors linked to rheumatoid arthritis. Learn about cutting-edge ultrasound techniques enhancing psoriatic arthritis diagnoses and the promising effects of upadacitinib for giant cell arthritis management.

Discover groundbreaking insights from the ACR Annual Meeting, highlighting the latest in rheumatology research. Explore the complexities of managing difficult axial spondyloarthritis and the nuances in treatment options for psoriatic arthritis. Delve into the promising yet costly advancements in CAR T cell therapy. Learn about intriguing gender differences in biologics efficacy for AXPA patients. Finally, uncover the vital role of imaging in managing giant cell arteritis, revealing the challenges in aligning clinical decisions with patient scans.

Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood  Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr. Richard Conway Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy Highlights in axSpA:Dr. Marina Magrey Hot Topics in axSpA:Dr. Marina Magrey Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.  Antoni Chan interviews Dr. Catherine Bakewell PsA Potpourri:Dr. Arthur Kavanaugh RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan  Kay interviews Dr. Cécile Gaujoux-Viala RA: One JAK to Rule Them All?:Dr. Brian Jaros What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych  

Dive into the latest on rheumatic diseases, starting with the fast-acting benefits of JAK inhibitors compared to TNF inhibitors. Discover paroxynase-1 as a potential predictor for arthritis progression. Weight loss drugs are making waves in psoriatic arthritis treatment, but is their effect sustainable? Explore how gender influences disease activity measures, and learn about upadacitinib's success in treating giant cell arteritis while tackling the complexities of CAR-T therapies. It's a treasure trove of insights!

Dive into the fascinating developments from ACR Convergence 2024! Discover the pressing need for improved monitoring in scleroderma-associated lung disease. Uncover insights into the survival rates of lung cancer patients with rheumatoid arthritis, showing no significant mortality difference. Explore the implications of tapering prednisone in granulomatosis with polyangiitis, highlighting crucial flare rate findings. Lastly, learn how ACR is evolving its educational practices through digital tools and social media, enhancing collaboration and knowledge-sharing.